Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more

Dave & Buster's plunged 17% after Q2 revenue of $544.1 million missed the $556.8 million consensus, adjusted EBITDA of $98.9 million trailed the expected $120.4 million, and it posted a $0.27 adjusted loss versus an anticipated $0.18 profit. Enova fell more than 25% after withdrawing regulatory applications for its proposed Grasshopper Bancorp acquisition, despite reaffirming guidance and accelerating buybacks, while Alignment Healthcare dropped 18% on acute-care and skilled-nursing utilization headwinds. Offsetting gains included Skyworks (+10%), Qorvo (+7%), Revvity (+7%) and Waystar (+8%+) amid reported take-private interest; crypto-linked shares declined ahead of a Senate vote on the Clarity Act.

Analysis

The largest fundamental signal is not the headline revenue miss in PLAY but the EBITDA shortfall: it points to operating deleverage in a discretionary concept with high fixed labor, occupancy and maintenance costs. That raises the probability of further estimate cuts over the next 1-3 months and is a modest negative read-through for experiential dining peers such as EAT and CBRL, particularly if traffic trends—not one-off costs—drove the miss. PLAY’s balance-sheet flexibility and same-store-sales trajectory are the key falsifiers; stabilization in weekly traffic or a credible cost-reset would make the post-earnings decline less actionable.

ALHC’s medical-cost commentary matters more for the Medicare Advantage group than its unchanged annual guide implies. Skilled-nursing length-of-stay inflation can emerge with a lag in reported medical-loss ratios, leaving 2026 consensus margins vulnerable if utilization fails to normalize; HUM and CVS deserve monitoring for any corroboration in upcoming utilization disclosures. The differentiated risk is ALHC’s institutional-acuity exposure, so a broad MA short is premature absent similar commentary from larger peers.

SWKS and QRVO’s rebound is tradable only if it becomes a broader evidence-based reset in handset inventory and content expectations. QRVO has relatively greater exposure to higher-value RF content and diversification beyond premium smartphones, while SWKS remains more concentrated and therefore more vulnerable if the recovery is merely short-covering after an AI-related de-risking. RVTY’s order conversion supports nearer-term revenue visibility, but at a 52-week high the market will require sustained organic growth and margin conversion rather than backlog alone to justify further multiple expansion.

COIN, RIOT and MSTR face a binary legislative-risk window rather than a clean Bitcoin-beta setup. A favorable regulatory outcome could compress the perceived legal discount for COIN, but miners remain exposed to network economics and MSTR retains embedded leverage to Bitcoin; neither is interchangeable with a regulatory catalyst trade. WAY’s takeover speculation has asymmetric upside only if credible bids emerge, but absent price, financing and sponsor details it is an event-driven watch item rather than a recommended position.

Key Decisions for Investors

• Initiate a 1-3 month short PLAY only after the initial volatility settles or on a failed rebound; target further consensus EBITDA revisions rather than another one-day gap. Risk-manage with a stop if management demonstrates traffic stabilization and protects forward EBITDA expectations.
• Maintain a relative long QRVO / short SWKS basket over 1-3 months, sized modestly, contingent on confirmation that handset inventory and RF-content assumptions are improving. Exit if either company cuts handset-related guidance or if the relative move is not supported by revised estimates.
• Place an alert on ALHC and the MA complex around the next utilization and medical-loss-ratio updates; consider ALHC puts or a short ALHC / long HUM relative trade only if skilled-nursing or acute-utilization pressure appears in subsequent disclosures. Unchanged 2026 guidance currently prevents a high-conviction directional short.
• Do not chase RVTY at the high; buy only on a pullback if third-quarter shipment conversion validates backlog quality and organic-growth estimates rise. The thesis fails if order conversion does not translate into revenue and operating-margin upside.
• Treat COIN as the preferred liquid expression of a favorable legislative resolution, using defined-risk call spreads around the vote rather than RIOT or MSTR. Close quickly if the regulatory process is delayed or Bitcoin fails to recover, as the catalyst is event-specific rather than fundamental.